← FDA Drug Approvals (Drugs@FDA)

ERLOTINIB HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2014-06-11

Drug application

FDA Application #

ANDA091002

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERLOTINIB HYDROCHLORIDE

Generic name

Erlotinib Hydrochloride

Active ingredients

ERLOTINIB HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

RISING

First approval

2014-06-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown